Article Text

PDF
Rheumatoid arthritis in Dubai—delayed diagnosis and low usage of disease modifying antirheumatic drugs
  1. Humeira Badsha1,
  2. K Ooi Kong2,
  3. P P Tak3
  1. 1Dubai Bone & Joint Center LLC, Dubai, United Arab Emirates
  2. 2Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore
  3. 3Academic Medical Center, University of Amsterdam. Amsterdam, The Netherlands
  1. Correspondence to:
    Dr H Badsha
    Dubai Bone & Joint Center LLC, Level 50, Emirates Towers, POBox 118855, Dubai, United Arab Emirates; humeira.badsha{at}dbaj.ae

Statistics from Altmetric.com

Information on rheumatoid arthritis (RA) among Arab populations in the Middle East is scarce. Studies have suggested that patients with RA living in Arab countries have similar clinical features, but less extra-articular manifestations, compared with those living in Western countries.1–4 Therefore, the aim of our study was to prospectively gather data on patients with RA who presented to a newly established musculoskeletal disease centre in Dubai (United Arab Emirates).

Demographic and clinical data were collected over a 10-month period for patients meeting the American College of Rheumatology criteria for RA. All statistical analyses were performed using Intercooled STATA V.8.2.

A total of 47 patients, consisting …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.